Zilver 635 Vascular Stent, Zilver 518 Vascular Stent
Cook Ireland, Ltd. · Decision date Nov 6, 2026
What did the FDA decide?
FDA database entry P050017/S027 is a supplement tied to PMA P050017, not a new PMA. The record says the decision was OK30 and the supplement type was a 30-Day Notice for a process change. The changed item is described only as new equipment used for manufacturing packaging; the filing text does not name the equipment, the packaging step, or any changed material.
The original scope named in the record is the Zilver® PTX® Drug-Eluting Peripheral Stent and the Zilver® Vascular Stent. The database text gives the regulatory purpose of the supplement, but it does not state any new indication, clinical outcome, or performance claim.
FDA approval order statement
approval of new equipment used for manufacturing packaging for the Zilver PTX Drug-Eluting Peripheral Stent and Zilver Vascular Stent
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 6, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P050017/S027
- Regulatory pathway
- PMA supplement
- Applicant
- Cook Ireland, Ltd.
- Product code
- NIO
- Decision code
- OK30
- Decision date
- Nov 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Cook Ireland, Ltd.
- Product code
- NIO
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P050017. Subsequent supplements may change the device or its indications.
FDA decision timeline
P050017 · Original PMA
ZILVER VASCULAR STENT
P050017/S027 received
Application receipt date recorded by FDA.
P050017/S027 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P050017. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P050017
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ZILVER VASCULAR STENTP050017 | Cook Ireland, Ltd. | PMA approval | Jun 26, 2006 | FDA |
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
S.M.A.R.T. CONTROL Nitinol Stent SystemP020036/S061 | Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA | |
| Biotronik AG | PMA approval | Dec 17, 2015 | FDA | |
INTRASTENT DOUBLESTRUT STENTP030045 | Medtronic Vascular, Inc. | PMA approval | Jun 8, 2004 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cook Ireland, Ltd.
- Headquarters
- Not reported
- Brand website
- cookmedical.com
- FDA applicant address
- O' Halloran Rd., National Technology Park, Limerick
Sources and methodology
- Original FDA record: P050017/S027
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



